IL297703A - Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa - Google Patents

Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa

Info

Publication number
IL297703A
IL297703A IL297703A IL29770322A IL297703A IL 297703 A IL297703 A IL 297703A IL 297703 A IL297703 A IL 297703A IL 29770322 A IL29770322 A IL 29770322A IL 297703 A IL297703 A IL 297703A
Authority
IL
Israel
Prior art keywords
conjugate
dcn
tcrk
decorin
agent
Prior art date
Application number
IL297703A
Other languages
English (en)
Hebrew (he)
Original Assignee
Tampere Univ Foundation Sr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tampere Univ Foundation Sr filed Critical Tampere Univ Foundation Sr
Publication of IL297703A publication Critical patent/IL297703A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725Proteoglycans, e.g. aggreccan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL297703A 2020-04-28 2021-04-28 Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa IL297703A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063016359P 2020-04-28 2020-04-28
FI20205431 2020-04-28
PCT/FI2021/050318 WO2021219940A1 (en) 2020-04-28 2021-04-28 Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa

Publications (1)

Publication Number Publication Date
IL297703A true IL297703A (en) 2022-12-01

Family

ID=75870661

Family Applications (1)

Application Number Title Priority Date Filing Date
IL297703A IL297703A (en) 2020-04-28 2021-04-28 Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa

Country Status (10)

Country Link
US (1) US20230167162A1 (https=)
EP (1) EP4142771A1 (https=)
JP (1) JP7824885B2 (https=)
KR (1) KR20230005314A (https=)
CN (1) CN115605218B (https=)
AU (1) AU2021266157A1 (https=)
BR (1) BR112022021879A2 (https=)
CA (1) CA3180694A1 (https=)
IL (1) IL297703A (https=)
WO (1) WO2021219940A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118001404B (zh) * 2024-02-06 2025-02-25 四川大学华西医院 抑制C17orf67基因表达试剂在制备治疗获得性大疱表皮松解症药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136869A2 (en) 2006-12-06 2008-11-13 Burnham Institute For Medical Research Methods and compositions related to targeting wounds, regenerating tissue, and tumors

Also Published As

Publication number Publication date
CN115605218A (zh) 2023-01-13
CA3180694A1 (en) 2021-11-04
BR112022021879A2 (pt) 2022-12-20
JP2023523719A (ja) 2023-06-07
WO2021219940A1 (en) 2021-11-04
AU2021266157A1 (en) 2022-12-08
CN115605218B (zh) 2026-03-24
JP7824885B2 (ja) 2026-03-05
EP4142771A1 (en) 2023-03-08
US20230167162A1 (en) 2023-06-01
KR20230005314A (ko) 2023-01-09

Similar Documents

Publication Publication Date Title
JP7693290B2 (ja) Larファミリーホスファターゼの活性を阻害する組成物及び方法
EP3065765B1 (en) Use of il-22 dimers in manufacture of medicaments for treating pancreatitis
JP6339231B2 (ja) 線維症性疾患の処置のためのTrailレセプターアゴニスト
US20190247317A1 (en) Icam-1 targeting elps
US20130210747A1 (en) Methods and Therapeutics Comprising Ligand-Targeted ELPs
US9901620B2 (en) Trail receptor agonists for treatment of fibrotic disease
US9308277B2 (en) Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
US20230167162A1 (en) Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa
CN105939724B (zh) 用于治疗和预防转移癌的药物组合物和方法
CN114409733A (zh) 靶向抑制mlkl乙酰化的多肽和/或其衍生物及其用途
US20170326166A1 (en) Compositions and methods for treating pituitary tumors
US20190022239A1 (en) Novel biomolecule conjugates and uses therefor
Pemmari et al. Domain in Homing Peptide Yields Skin-Targeted Therapeutic in Epidermolysis Bullosa
HK1236396A1 (en) Trail receptor agonists for treatment of fibrotic diseases
HK1223556B (zh) Il-22二聚体在制备用於治疗胰腺炎的药物中的用途